Citri to activate sales of anti-fungal drug, Terbinafine,
Published: 2003-06-12 07:10:00
Updated: 2003-06-12 07:10:00
Citri (President: Kim Wan-joo) is now launching Terbinafine, an anti-fungal tablet, into the market under the co-marketing agreement with Goodmorning Pharm. Co. on May 30, mainly targeting hospitals and private clinics starting from June 1.
They estimated the total world market potentiality ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
